MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients

G. Caramori, P. Casolari, M. Saetta, S. Baraldo, K. Ito, L. M. Fabbri, P. J. Barnes, I. M. Adcock, G. Cavallesco, K. F. Chung, A. Papi (Ferrara, Padova, Modena, Italy; London, United Kingdom)

Source: Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Session: Recent advances in the treatment of COPD and acute lung injury
Session type: Thematic Poster Session
Number: 3849
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Caramori, P. Casolari, M. Saetta, S. Baraldo, K. Ito, L. M. Fabbri, P. J. Barnes, I. M. Adcock, G. Cavallesco, K. F. Chung, A. Papi (Ferrara, Padova, Modena, Italy; London, United Kingdom). MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients. Eur Respir J 2006; 28: Suppl. 50, 3849

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009


ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
Source: Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020
Year: 2020



Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010


Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
Source: Eur Respir J, 56 (2) 2002378; 10.1183/13993003.02378-2020
Year: 2020



Bronchial airway expression of mucin-related, ENaC and chloride channel genes in COPD and non-COPD smokers compared to former and never smokers
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers)
Source: International Congress 2017 – Smoking and health hazards
Year: 2017

Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Effect of whole cigarette smoke exposure and CCSP on MUC5AC mucin production in primary cultures of human bronchial epithelial cells at air-liquid interface of COPD, smokers and control patients
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013



Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001

The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Asthma control is worse in asthmatic smokers compared to non-smokers with similar lung function
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006


Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005


Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 321s
Year: 2004

COPD, asthma, and lung cancer patients
Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups
Year: 2016



Airway obstruction and or emphysema shows a different plasma inflammatory response in asymptomatic smokers or ex-smokers participating in a lung cancer screening program
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010


Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD
Source: Eur Respir J 2002; 20: 556-563
Year: 2002